Bladder CancerPub Date : 2021-01-01DOI: 10.1007/978-3-030-70646-3_39
R. Shotton, A. Birtle
{"title":"Selection, Administration and Description of Neoadjuvant versus Adjuvant Therapy for Upper Tract Urothelial Carcinoma","authors":"R. Shotton, A. Birtle","doi":"10.1007/978-3-030-70646-3_39","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_39","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"28 6: High Density Integr. Multipurpose Photon. Circ.","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50974396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bladder CancerPub Date : 2021-01-01DOI: 10.1007/978-3-030-70646-3_14
S. Ghodoussipour, S. Daneshmand, F. Burkhard, B. Kiss, G. Thalmann, N. Aldhaam, A. Elsayed, A. Hussein, K. Guru, M. Moschini, M. Saad, X. Cathelineau, R. Sanchez-Salas, Utsav K Bansal, S. Lerner
{"title":"Radical Cystectomy","authors":"S. Ghodoussipour, S. Daneshmand, F. Burkhard, B. Kiss, G. Thalmann, N. Aldhaam, A. Elsayed, A. Hussein, K. Guru, M. Moschini, M. Saad, X. Cathelineau, R. Sanchez-Salas, Utsav K Bansal, S. Lerner","doi":"10.1007/978-3-030-70646-3_14","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_14","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"29 4: Biophotonics","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50973939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bladder CancerPub Date : 2021-01-01DOI: 10.3233/blc-201535
Ryan M Reyes, Emily Rios, Shane Barney, Cory M Hugen, Joel E Michalek, Yair Lotan, Edward M Messing, Robert S Svatek
{"title":"A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer.","authors":"Ryan M Reyes, Emily Rios, Shane Barney, Cory M Hugen, Joel E Michalek, Yair Lotan, Edward M Messing, Robert S Svatek","doi":"10.3233/blc-201535","DOIUrl":"10.3233/blc-201535","url":null,"abstract":"<p><strong>Background: </strong>Surveillance regimens for non-muscle invasive bladder cancer (NMIBC) are disparate and controlled trials could inform guidelines. The feasibility of randomizing patients to variable frequency surveillance is unknown.</p><p><strong>Objectives: </strong>To determine patient willingness to randomization to high frequency (HF) versus low frequency (LF) surveillance regimen for NMIBC and compare patient comfort and healthcare costs across regimens.</p><p><strong>Methods: </strong>A non-blinded, two-arm, randomized-controlled study of patients with low or low-intermediate risk NMIBC was conducted at two institutions where patients were offered randomization to HF vs. LF surveillance following initial tumor resection. The HF group underwent cystoscopy every three months for 2 years, then every 6 months for 2 years, then annually. The LF group underwent cystoscopy at 9 months following the 3-month cystoscopy, then annually. Assuming 75% of patients approached would agree to enrollment, a sample size of <i>n</i> = 35 patients per arm provided a one-sided 95% exact Clopper-Pearson confidence lower-limit of 60%.</p><p><strong>Results: </strong>Of 70 patients approached, 45 (64.3%) agreed to participate and 25 (35.7%) declined enrollment due to preference for HF. Twelve biopsies were performed, including 4 (19%) of 21 patients in the HF group and 8 (33.3%) of 24 patients in the LF group. Disease recurrence (low grade Ta) was observed in 3 (14.3%) and 5 (20.8%) patients in the HF and LF groups, respectively. No patients experienced high grade recurrence or progression. Both groups had similar patient-reported procedure-related discomfort and quality of life measures over time. Patient out-of-pocket cost and healthcare systems costs were $383.80 more per patient annually in the HF group.</p><p><strong>Conclusions: </strong>Randomization to variable frequency surveillance is challenging as over a third of patients declined participation. However, these data provide important preliminary insights into the potential effects of surveillance frequency on oncologic and economic outcomes in patients with low and low-intermediate risk bladder cancer.</p>","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"7 3","pages":"285-295"},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/blc-201535","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39498272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bladder CancerPub Date : 2021-01-01DOI: 10.1007/978-3-030-70646-3_1
J. Meeks
{"title":"Bladder Cancer Screening, Signs and Symptoms, and Workup","authors":"J. Meeks","doi":"10.1007/978-3-030-70646-3_1","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_1","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"12 1","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50973566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bladder CancerPub Date : 2021-01-01Epub Date: 2021-12-13DOI: 10.3233/blc-200428
Syed M Alam, Carrie Michel, Hilary Robertson, Juliana T Camargo, Brenda Linares, Jeffrey Holzbeierlein, Jill Hamilton-Reeves
{"title":"Optimizing Nutritional Status in Patients Undergoing Radical Cystectomy: A Systematic Scoping Review.","authors":"Syed M Alam, Carrie Michel, Hilary Robertson, Juliana T Camargo, Brenda Linares, Jeffrey Holzbeierlein, Jill Hamilton-Reeves","doi":"10.3233/blc-200428","DOIUrl":"10.3233/blc-200428","url":null,"abstract":"<p><strong>Background: </strong>Nutrition is a modifiable risk factor for patients undergoing multimodal oncologic interventions and plays a major supportive role in the setting of bladder cancer. For patients undergoing radical cystectomy (RC), malnutrition is associated with increased postoperative complications and mortality.</p><p><strong>Objectives: </strong>The purpose of this scoping review is to characterize the role of nutritional interventions for patients undergoing RC for bladder cancer.</p><p><strong>Methods: </strong>A multi-database systematic scoping review based on the Preferred Reporting Items for Systematic Reviews extension for Scoping Reviews (PRISMA-ScR) guidelines was performed. Search terms were developed <i>a priori</i> to identify clinical trials that focused on nutritional interventions for patients with bladder cancer undergoing RC. Eligible articles were original research articles or abstracts from clinical trials evaluating nutritional interventions in adult patients undergoing RC. Articles were excluded if they did not focus on a nutritional intervention, if patients did not carry a diagnosis of bladder cancer, or if RC was not performed. Articles were reviewed independently by the authors, and inclusion/exclusion were based on consensus agreement.</p><p><strong>Results: </strong>A total of 83 articles were identified, of which 17 were included in the final analysis. A total of 49 articles were excluded during abstract screening. An additional 17 articles were excluded based on the review of full-text articles. Results of the scoping review suggest that data on the use of nutritional screening, assessment, and intervention for patients undergoing RC are scarce. Although parenteral nutrition (PN) appears to be associated with greater complications after RC, early introduction of food postoperatively or feeding enterally offers benefit and immunonutrition supplements with a focus on a high protein diet has the potential to better optimize surgical outcomes.</p><p><strong>Conclusions: </strong>Although the prevalence and consequences of malnutrition among patients undergoing RC are well-established, there are limited data evaluating the use of nutritional screening, assessment, and interventions for this population. The pursuit of future clinical trials in this space is critical.</p>","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"7 4","pages":"449-461"},"PeriodicalIF":1.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/66/a0/blc-7-blc200428.PMC8730471.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39791992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bladder CancerPub Date : 2021-01-01DOI: 10.1007/978-3-030-70646-3_13
Vishnukamal Golla, K. Chamie
{"title":"Oncological Monitoring of NonMuscle Invasive Bladder Cancer (NMIBC)","authors":"Vishnukamal Golla, K. Chamie","doi":"10.1007/978-3-030-70646-3_13","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_13","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"54 6","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50973927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bladder CancerPub Date : 2021-01-01DOI: 10.1007/978-3-030-70646-3_3
R. Ghandour, N. Singla, Y. Lotan
{"title":"Using Urinary Biomarkers in Urothelial Carcinoma of the Bladder and Upper Tracts","authors":"R. Ghandour, N. Singla, Y. Lotan","doi":"10.1007/978-3-030-70646-3_3","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_3","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"74 3","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50974153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}